All changes made to the description and title of this
division.
View division
|
Edit description
| Change |
Division |
|
senate vote 2022-10-27#8
Edited by
mackay staff
on
2023-01-06 12:19:03
|
Title
Committees — Finance and Public Administration References Committee; Reference- Committees - Finance and Public Administration References Committee - Reference; COVID-19 measures
Description
<p class="speaker">Gerard Rennick</p><p>I move:</p>-
- The majority voted against a [motion](https://www.openaustralia.org.au/senate/?id=2022-10-27.112.1) introduced by Queensland Senator [Gerard Rennick](https://theyvoteforyou.org.au/people/senate/queensland/gerard_rennick) (Liberal), which means it failed.
- ### Motion text
- > *That the following matter be referred to the Finance and Public Administration References Committee for inquiry and report by 21 November 2022:*
- >
- > *The efficacy of previous and ongoing measures to respond to COVID-19 in Australia, with particular reference to:*
- >
- > *(a) COVID-19 vaccines rolled out in Australia, including:*
- >
- >> *(i) pharmacological evidence and safety data regarding toxicity, genotoxicity and teratogenicity,*
- >>
- >> *(ii) vaccines and boosters that have been subject to provisional approval in Australia or emergency use authorisations in other countries, and*
- >>
- >> *(iii) adverse events related to COVID-19 vaccines;*
- >
- > *(b) antiviral treatments including Remdesivir and new treatments subject to provisional approval in Australia or emergency use authorisations in other countries;*
- >
- > *(c) other measures including:*
- >
- >> *(i) vaccine mandates,*
- >>
- >> *(ii) mask mandates,*
- >>
- >> *(iii) social distancing mandates,*
- >>
- >> *(iv) lockdowns, and*
- >>
- >> *(v) travel restrictions, including the closure of state and international borders;*
- >
- > *(d) the role of National Cabinet in responding to COVID-19, and the Australian Health Practitioner Regulation Authority regulating medical professionals raising concerns about COVID-19 treatments; and*
- >
- > *(e) any related matters.*
<p class="italic">That the following matter be referred to the Finance and Public Administration References Committee for inquiry and report by 21 November 2022:</p><p class="italic">The efficacy of previous and ongoing measures to respond to COVID-19 in Australia, with particular reference to:</p><p class="italic">(a) COVID-19 vaccines rolled out in Australia, including:</p><p class="italic">(i) pharmacological evidence and safety data regarding toxicity, genotoxicity and teratogenicity,</p><p class="italic">(ii) vaccines and boosters that have been subject to provisional approval in Australia or emergency use authorisations in other countries, and</p><p class="italic">(iii) adverse events related to COVID-19 vaccines;</p><p class="italic">(b) antiviral treatments including Remdesivir and new treatments subject to provisional approval in Australia or emergency use authorisations in other countries;</p><p class="italic">(c) other measures including:</p><p class="italic">(i) vaccine mandates,</p><p class="italic">(ii) mask mandates,</p><p class="italic">(iii) social distancing mandates,</p><p class="italic">(iv) lockdowns, and</p><p class="italic">(v) travel restrictions, including the closure of state and international borders;</p><p class="italic">(d) the role of National Cabinet in responding to COVID-19, and the Australian Health Practitioner Regulation Authority regulating medical professionals raising concerns about COVID-19 treatments; and</p><p class="italic">(e) any related matters.</p> <p class="speaker">Sue Lines</p><p>The question is that business of the Senate notice of motion No. 3, standing in the name of Senator Rennick, be agreed to.</p><p></p><p></p><p></p> -
-
|